You are using an unsupported browser.

Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

Sorry, your browser window is too small.

Some features of this site may not function properly. For optimal user experience, please view this site in a larger browser window.

For US Healthcare ProfessionalsFor US HCPs

GSK Vaccination

Tell us what you are looking for in the search box.

ACCESS GSKPRO

SHINGLES

Shingles, herpes zoster, is caused by the reactivation of the varicella zoster virus. Shingles causes a painful blistering rash that typically lasts up to 2 to 4 weeks.¹ Shingles can lead to serious, long-lasting complications, including postherpetic neuralgia (PHN) and herpes zoster ophthalmicus (HZO). PHN can result in long-term pain in the area where the rash was and occurs in 10%-18% of cases. HZO can occur in 10%-25% of cases and could lead to ocular complications and, in rare cases, vision loss.^1-3

Facts About Shingles

An estimated 1 million cases occur annually in the United States.¹

Shingles can be painful and can lead to serious, long-lasting complications.¹

99.5% of people 50 years and older are infected with the varicella zoster virus (VZV).¹

In 1 out of 3 people, the dormant virus reactivates and causes shingles.¹

Starting at 50 years old, shingles risk sharply increases.³

Direct contact with active blisters can cause chickenpox in people who have never had chickenpox or the chickenpox vaccine.⁴

Shingles Vaccination Eligibility and Administration Information

The Centers for Disease Control and Prevention (CDC) recommends vaccination for the prevention of herpes zoster and related complications for immunocompetent adults aged 50 years and older and adults 19 years and older who are or will be immunodeficient or immunosuppressed because of disease or therapy.⁵ Please refer to the CDC Immunization Schedule for the complete shingles recommendation.

Shingles Downloadable Resources

Pharmacist Resources

Information Statement

Shingles Multicultural Leave-Behind

download

Pharmacist Resources

Pharmacy Technician Leave-Behind

download

Download Shingles Pharmacist Resources

download

Shingles Resources

Learn about a Shingles Vaccine and Find Resources

References

Shingles (herpes zoster). Clinical overview. Centers for Disease Control and Prevention. Reviewed May 10, 2023. Accessed January 30, 2024. https://www.cdc.gov/shingles/hcp/clinical-overview.html
Shingles (herpes zoster). Signs and symptoms. Centers for Disease Control and Prevention. Reviewed May 10, 2023. Accessed January 30, 2024. https://www.cdc.gov/shingles/about/symptoms.html
Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2008;57(RR-5):1-30.
Shingles (herpes zoster). Cause and transmission. Centers for Disease Control and Prevention. Reviewed May 10, 2023. Accessed January 30, 2024. https://www.cdc.gov/shingles/about/transmission.html
Recommended adult immunization schedule for ages 19 years or older, 2024. Centers for Disease Control and Prevention. Reviewed December 28, 2023. Accessed February 21, 2024. https://www.cdc.gov/vaccines/schedules/downloads/adult/adult-combined-schedule.pdf

Trademarks are owned by or licensed to the GSK group of companies.